
CUMAb: A tool for Computational hUMan AntiBody design
CUMAb is an antibody optimization method, and its academic use is free. If academic use of the results leads to applications with commercial potential, please obtain a license to the results from the Weizmann Institute’s technology transfer office Yeda. Commercial users or academic users conducting commercially sponsored research should refer to Scala Biodesign which holds an exclusive license for such uses.
NEW! a Hands-on tutorial for using the Fleishman lab
protein-optimisation workflows
Selected citations and patents
Questions and support
Overview & questions: contact us
Commercial users
Please contact Scala Biodesign
Citation
Please cite Tennenhouse et al. Nat Biomed Eng 2024
PMID: 37550425 HTML
Algorithm development
Ariel Tennenhouse & Sarel Fleishman
Web interface: Rotem Barzilay and Shi Hoch
Terms and conditions
Use of the output, the variants and their derivatives is subject to the terms and conditions and may be used for academic research only, excluding commercially sponsored research. Accordingly, commercial use of the attached variants or their derivatives is unauthorized without prior written approval by Yeda.